Details of the Drug

General Information of Drug (ID: DMON7OL)

Drug Name
Apo805K1
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Phase 2 [1]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C16H18KN3O5
Canonical SMILES
[H+].C1=CC=C2C(=C1)C(=CN2)CC(C(=O)[O-])NC(=O)CCC(C(=O)[O-])N.[K+]
InChI
InChI=1S/C16H19N3O5.K/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12;/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24);/q;+1/p-1/t11-,13-;/m1./s1
InChIKey
JBUWHGCMOSDECA-LOCPCMAASA-M
Cross-matching ID
PubChem CID
76318569
CAS Number
960155-19-5
TTD ID
D06HQM

References

1 ClinicalTrials.gov (NCT01483924) Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis. U.S. National Institutes of Health.